Attached to strands of DNA, they change shape, size, and chemistry to access diseased tissue, like a key fitting into a lock
Meet Deep Genomics, a privately-held company that seeks to harness the power of deep learning to transform medicine.
U of T experts suggest crystalized materials may hold wide commercial potential.
CURRENT ISSUE - May/June 2025
Joining Processes And Software For a Streamlined, Quality-First Laboratory